Form 4: Natera Executive Chairman Sells Shares Under 10b5-1 Plan

Natera's Executive Chairman, Matthew Rabinowitz, exercised stock options and subsequently sold a significant number of common shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Matthew Rabinowitz, Executive Chairman and Director of Natera, Inc. (NTRA), reported transactions involving the company's common stock.
• On March 12, 2026, Mr. Rabinowitz acquired 75,000 shares of common stock by exercising stock options at a price of $9.59 per share.
• On the same day, he disposed of a total of 74,998 common shares in multiple transactions at weighted average prices ranging from $186.7494 to $195.32 per share.
• On March 13, 2026, he acquired another 75,000 shares by exercising stock options at $9.59 per share.
• Also on March 13, 2026, he sold a total of 74,900 common shares at weighted average prices ranging from $187.6288 to $191.2227 per share.
• On March 16, 2026, he acquired 50,000 shares through option exercise at $9.59 per share.
• On March 16, 2026, he sold a total of 49,900 common shares at weighted average prices ranging from $190.0708 to $198.0204 per share.
• All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025.
• Following these transactions, Mr. Rabinowitz directly beneficially owns 2,310,772 shares of common stock and indirectly owns 5,000 shares through his spouse.
• He also holds 100,000 derivative securities in the form of stock options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While significant insider selling can sometimes be perceived negatively, the transactions were executed under a pre-arranged 10b5-1 plan, indicating planned diversification rather than a reaction to new, adverse company developments.

Positives

• The exercise of stock options at a low price of $9.59 and subsequent sale at significantly higher prices (up to $198.17) indicates substantial personal gain for the executive, reflecting value creation for long-term option holders.
• The transactions were executed under a Rule 10b5-1 trading plan, which provides transparency and suggests the sales were pre-planned for diversification or liquidity rather than being reactive to new, adverse information.

Negatives

• The significant volume of insider selling, totaling 199,798 shares, could be perceived negatively by some investors, potentially raising questions about management's long-term confidence, despite the 10b5-1 plan.

Risks

• Potential for negative market perception if investors misinterpret the insider selling as a lack of confidence in the company's future, despite the pre-planned nature of the transactions.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider selling, even under a 10b5-1 plan, is a common practice for executives to diversify holdings and manage personal finances. However, the volume and timing can sometimes influence market sentiment, especially if not clearly communicated as part of a pre-planned strategy.

Comparison to Industry Standards

• StockSavvy.ai observes that the use of Rule 10b5-1 trading plans is a standard corporate governance practice among executives at publicly traded companies like Natera. This mechanism provides an affirmative defense against insider trading allegations by allowing insiders to set up pre-scheduled trades when they are not in possession of material non-public information.
• Many executives at peer companies in the biotechnology and diagnostics sector, such as Illumina (ILMN) or Guardant Health (GH), utilize similar plans for liquidity and diversification purposes.
• The significant spread between the exercise price ($9.59) and the sale prices (up to $198.17) is typical for long-held options in successful growth companies, reflecting substantial value creation over time.

Related Party Transactions

• 5,000 shares of common stock are indirectly beneficially owned by the reporting person through his spouse.

Stakeholder Impact

• Shareholders might interpret the selling as a lack of immediate confidence, but the execution under a 10b5-1 plan mitigates this concern by indicating a pre-planned financial strategy rather than a reaction to new company-specific news.

Key Dates

Recommendation

The transactions represent routine, pre-planned insider selling under a 10b5-1 plan, which is common for executives to manage personal finances and diversify holdings. It does not signal new material information about the company's prospects, thus a 'hold' recommendation is appropriate as the filing itself doesn't provide a basis for a change in investment thesis.

Keywords

Natera, NTRA, Form 4, insider trading, stock options, 10b5-1 plan, Matthew Rabinowitz, share sale, executive chairman, beneficial ownership